Veralto (VLTO) Q2 2026 earnings review
Growth Accelerates and Guidance Rises, Bolstered by Tariff Recoveries
Veralto delivered a robust second quarter, breaking out of a recent slow-growth pocket with a sequential acceleration to 4.2% core sales growth. The outperformance was heavily skewed toward Water Quality (+5.7% core), while the Product Quality & Innovation (PQI) segment lagged (+2.0%). While management touted a 19% surge in Adjusted EPS to $1.11, investors should note this includes a $0.05 per share one-time benefit from IEEPA tariff recoveries. Nevertheless, strong free cash flow generation and the integration of new bolt-on acquisitions prompted a solid upward revision to both full-year sales and EPS guidance.
🐂 Bull Case
Water Quality core sales jumped 5.7%, accelerating significantly from 3.8% last quarter. The segment is successfully capitalizing on persistent demand across industrial water treatment, reuse initiatives, and steady municipal markets.
Adjusted operating profit margins expanded 90 basis points year-over-year to 24.6%. The company's Veralto Enterprise System (VES) continues to drive operating leverage even as they integrate new acquisitions.
🐻 Bear Case
The reported 19% Adjusted EPS growth looks impressive, but roughly 5.5% of that growth ($0.05/share) was driven by an IEEPA tariff refund, masking slightly softer underlying operational flow-through.
Product Quality & Innovation core sales grew only 2.0%. While a reversal from Q1's contraction, it remains a laggard. Management's guidance relies heavily on a 'meaningful' H2 acceleration in this specific segment.
⚖️ Verdict: 🟢
Bullish. The core business is accelerating exactly as management promised last quarter. While the tariff refund flatters the EPS beat slightly, the operational raise to full-year guidance and consistent robust cash flow demonstrate high-quality execution.
Key Themes
Water Quality Benefiting from Broad Macro Resilience
The Water Quality segment remains the primary growth engine, delivering 5.7% core sales growth. Management explicitly called out strong demand across both industrial water treatment and municipal operations. This confirms the narrative that Veralto's OPEX-driven, high-cost-of-failure products are largely insulated from broader macroeconomic capital expenditure cyclicality.
Aggressive Bolt-On M&A Execution
Veralto is rapidly deploying its cash flow into compounding M&A. The company announced the acquisition of Alfaa UV, stacking it on top of recent In-Situ and GlobalVision purchases. This execution directly supports their long-term growth algorithm and expands their footprint in targeted adjacent markets without straining the balance sheet.
Digital Workflow Adoption in Packaging
While overall PQI growth was muted, management highlighted digital workflow solutions in packaging and color as a strong underlying grower. They project increasing adoption of these specific digital products, along with recent new product launches, will act as the primary catalyst for accelerating PQI sales in the second half of the year.
PQI Segment Remains the Weakest Link
PQI core sales reversed their 1.0% contraction from Q1, printing 2.0% growth in Q2. However, this still heavily trails the company average and the Water Quality segment. Veralto's aggressive full-year guidance requires this segment to accelerate 'meaningfully' in H2. If CPG capital constraints or industrial weakness persist, this segment could jeopardize H2 targets.
EPS Growth Inflated by Tariff Recovery
Management prominently featured a 19% year-over-year increase in Adjusted EPS (to $1.11). However, $0.05 of this result came from a recovery of tariffs previously collected under the International Emergency Economic Powers Act (IEEPA). Excluding this one-time item, Adjusted EPS would have been $1.06, lowering the true operational growth rate to 14%—still strong, but contradicting the headline narrative of a 19% organic surge.
Restructuring Charges Highlight Margin Risks
The company recorded a $29 million pretax charge in Q2 related to the '2026 Cost Optimization Program'. While excluded from non-GAAP Adjusted Operating Profit, this cash outlay highlights the friction costs of protecting margins in a mixed demand environment. The execution risk of realizing the targeted savings from this program remains a key point to monitor.
Other KPIs
Free cash flow generation remains exceptional, coming in at $328M for the quarter (a 136% conversion rate of GAAP Net Earnings). TTM FCF sits at $1.047B with an 18.4% margin. This robust cash generation heavily insulates the balance sheet and fully funds the aggressive M&A pipeline without requiring new debt.
Accelerating. Up 90 basis points year-over-year from 23.7% in 25Q2. The margin expansion demonstrates strong pricing power and the successful early application of VES continuous improvement protocols, overcoming the integration drag of recent acquisitions.
Guidance
Accelerating vs current quarter. The midpoint of 4.5% represents a continued upward trajectory from Q2's 4.2% and Q1's 1.9%, signaling management's confidence that destocking and industrial headwinds are clearing.
Stable. The midpoint of $1.075 represents an 8.6% year-over-year increase compared to 25Q3's $0.99. This reflects solid core execution, shedding the one-time $0.05 tariff benefit seen in Q2.
Accelerating. Raised from the prior range of 3.0% to 4.5%. Management explicitly noted expectations for total core sales to accelerate to 5% to 6% in the second half of the year, a highly bullish indicator for end-market demand.
Accelerating. Raised from the prior range of $4.20 to $4.28. While $0.05 of this $0.15 midpoint raise is attributable to the Q2 tariff refund, the remaining $0.10 constitutes a pure operational upgrade, reflecting strong H1 execution and expected H2 acceleration.
Key Questions
Visibility into PQI Acceleration
You noted expectations for PQI core sales to accelerate 'meaningfully' in H2. Beyond digital workflow adoption, what specific leading indicators (order books, equipment quoting) give you confidence this highly anticipated inflection will materialize?
Alfaa UV Integration and M&A Pipeline
With the addition of Alfaa UV following In-Situ and GlobalVision, how is the pace of integration impacting segment operating margins, and does the strong FCF generation hint at an even larger, more transformational M&A target in the near term?
Cost Optimization Execution
You recorded a $29 million restructuring charge in Q2 for the 2026 Cost Optimization Program. What is the precise timeline for realizing these targeted savings, and are these savings earmarked for margin expansion or reinvestment into R&D?